Lupin gets final approval for Hydrocodone Bitartrate and Acetaminophen Tablets
From USFDA
Lupin announced that its subsidiary, Gavis Pharmaceuticals LLC, has received final approval for its Hydrocodone Bitartrate and Acetaminophen Tablets USP, 5mg/300mg, 7.5mg/300mg and 10mg/300mg from United States Food and Drug Administration to market a generic equivalent of MilKart Inc's Hydrocodone Bitartrate and Acetaminophen Tablets USP, 5mg/300mg, 7.5mg/300mg and 10mg/300mg.Powered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content